Bio-Rad buoyed by 2Q figures
Bio-Rad Laboratories defies the often-reported turndown in the life sciences supply industry with a healthy hike in second quarter sales and profits.
Archives for July 28, 2003
ASINEX gets new contract from J&J
Russia's ASINEX extends its discovery chemistry contract with J&J for an additional 12-month period; also launches three targeted compound libraries.
CYP450 variant licensed for genotyping
EPIDAUROS Biotechnologie has acquired a non-exclusive licence for the diagnostic use of one of the most important genetic variants of the cytochrome P450 2D6 gene.
Amersham trims 2003 profit forecast again
Amersham trimmed its 2003 profit forecast by £40 million (€57m), or 4.1 pence per share, after reporting lower sales and pre-tax profits for the first half of 2003.